What’s next for Medtronic’s RDN program after FDA approval? - podcast episode cover

What’s next for Medtronic’s RDN program after FDA approval?

Nov 28, 202310 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, November 28, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Philips this week unveiled its next-generation ultrasound systems. Fast Five hosts Sean Whooley and Danielle Kirsh go over the details of some of the new ultrasound systems and the executives' optimism.  Pristine Surgical has fully launched its single-use arthroscope in the U.S. Hear what the system does, how the system integrates into existing clinical workflows and the reaction from doctors so far.  Medtronic launched its left atrial appendage exclusion system. Whooley explains how the LAA system works and how it gives surgeons greater control during procedures.  GE HealthCare also unveiled new technology this week – an AI-powered breast cancer detection suite. The Fast Five hosts discuss what the suite does, what AI and software is integrated in the suite and how optimistic executives are about the future of breast cancer diagnostics.  Before we went on holiday break, the FDA approved Medtronic's renal denervation system. With the approval under its belt, Medtronic has big plans for the system's launch. Find out what those plans are and how it plans to achieve them.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
What’s next for Medtronic’s RDN program after FDA approval? | Fast Five Medtech News Podcast - Listen or read transcript on Metacast